Management of high hepatopulmonary shunting in patients undergoing hepatic radioembolization

Journal of Vascular and Interventional Radiology

Volumn 26, Issue 12, 2015, Pages 1751-1760

  Ward, Thomas J ^a   Tamrazi, Anobel ^b   Lam, Marnix G E H ^c   Louie, John D ^a   Kao, Peter N ^a   Shah, Rajesh P ^a   Kadoch, Michael A ^a   Sze, Daniel Y ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS; GLASS MICROSPHERE; MACROSALB TC 99M; MICROSPHERE; RESIN; RESIN MICROSPHERE; UNCLASSIFIED DRUG; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; BLAND ARTERIAL EMBOLIZATION; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; DISEASE CONTROL; FEMALE; FOLLOW UP; HEPATIC VEIN BALLOON OCCLUSION; HEPATOPULMONARY SHUNT FRACTION; HUMAN; LIVER CELL CARCINOMA; LIVER SCINTISCANNING; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY SHUNT; RADIATION DOSE; RADIOEMBOLIZATION; SHUNTING; TASK PERFORMANCE; TREATMENT PLANNING; TREATMENT RESPONSE; VARICEAL EMBOLIZATION; CALIFORNIA; COMORBIDITY; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HEPATOPULMONARY SYNDROME; INCIDENCE; LIVER NEOPLASMS; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

CALIFORNIA; COMORBIDITY; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84947917190     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2015.08.027     Document Type: Article

References (32)

1. A. Riaz, R.J. Lewandowski, L.M. Kulik, and et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol 20 2009 1121 1130
2. W.S. Chan, W.L. Poon, D.H. Cho, S.S. Chiu, and S.H. Luk Transcatheter embolisation of intrahepatic arteriovenous shunts in patients with hepatocellular carcinoma Hong Kong Med J 16 2010 48 55
3. S. Sugano, K. Miyoshi, T. Suzuki, T. Kawafune, and M. Kubota Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization Am J Gastroenterol 89 1994 184 188
4. C.L. Wright, J.D. Werner, J.M. Tran, and et al. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review J Vasc Interv Radiol 23 2012 669 674
5. T.W. Leung, W.Y. Lau, S.K. Ho, and et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors Int J Radiat Oncol Biol Phys 33 1995 919 924
6. A. Kennedy, S. Nag, R. Salem, and et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
7. W.Y. Lau, A.S. Kennedy, Y.H. Kim, and et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres Int J Radiat Oncol Biol Phys 82 2012 401 407
8. W.S. Snyder, M.R. Ford, G.G. Warner, and S.B. Watson MIRD pamphlet no. 11: S absorbed dose per unit cumulated activity for selected radionuclides and organs 1975 Society of Nuclear Medicine Reston, VA Available at: http://interactive.snm.org/docs/MIRD%20Pamphlet%2011.1-69.pdf. Accessed October 1, 2015
9. L. Bester, and R. Salem Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization J Vasc Interv Radiol 18 2007 1310 1314
10. E.A. Eisenhauer, P. Therasse, J. Bogaerts, and et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
11. US Department of Health and Human Services; National Institutes of Health; National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. Accessed February 1, 2015.
12. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
13. P.R. Graves, F. Siddiqui, M.S. Anscher, and B. Movsas Radiation pulmonary toxicity: from mechanisms to management Semin Radiat Oncol 20 2010 201 207
14. S. Ho, W.Y. Lau, T.W. Leung, M. Chan, P.J. Johnson, and A.K. Li Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur J Nucl Med 24 1997 293 298
15. R. Salem, P. Parikh, B. Atassi, and et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution Am J Clin Oncol 31 2008 431 438
16. M.G. Lam, A. Banerjee, M.L. Goris, and et al. Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types Eur J Nucl Med Mol Imaging 42 2015 1192 1201
17. M. Wondergem, M.L. Smits, M. Elschot, and et al. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization J Nucl Med 54 2013 1294 1301
18. M. Elschot, J.F. Nijsen, M.G. Lam, and et al. (99m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres Eur J Nucl Med Mol Imaging 41 2014 1965 1975
19. 90yttrium radioembolization of liver cancer Int J Radiat Oncol Biol Phys 85 2013 834 839
20. N. Pinjaroen, J. Kaufman, K.J. Kolbeck, K. Farsad, and L. Watson Clinical correlation between hepatic vein opacification and hepatopulmonary shunt fraction for 90Y evaluation J Vasc Interv Radiol 24 2013 S164
21. R.C. Gaba, S.P. Zivin, M.S. Dikopf, and et al. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting Radiology 271 2014 602 612
22. J.M. Theysohn, J.F. Schlaak, S. Muller, and et al. Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration J Vasc Interv Radiol 23 2012 949 952
23. S.C. Rose, and C.K. Hoh Hepatopulmonary shunt reduction using chemoembolization to permit yttrium-90 radioembolization J Vasc Interv Radiol 20 2009 849 851
24. R.C. Gaba, and K.A. Vanmiddlesworth Chemoembolic hepatopulmonary shunt reduction to allow safe yttrium-90 radioembolization lobectomy of hepatocellular carcinoma Cardiovasc Intervent Radiol 35 2012 1505 1511
25. S. Murata, H. Tajima, K. Nakazawa, S. Onozawa, S. Kumita, and K. Nomura Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts Eur Radiol 19 2009 2016 2023
26. A. Gramenzi, R. Golfieri, C. Mosconi, and et al. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis Liver Int 35 2015 1036 1047
27. X. Ding, W. Ji, J. Li, X. Zhang, and L. Wang Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer Radiat Oncol 6 2011 24
28. I.R. Vogelius, and S.M. Bentzen A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis Acta Oncol 51 2012 975 983
29. E. Garin, Y. Rolland, J. Edeline, and et al. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis J Nucl Med 56 2015 339 346
30. A.C. Bourgeois, T.T. Chang, Y.C. Bradley, S.N. Acuff, and A.S. Pasciak Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of yttrium-90 radioembolization J Vasc Interv Radiol 25 2014 271 275
31. K.T. Brown Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres J Vasc Interv Radiol 15 2004 197 200
32. P.C. Kwok, T.W. Lam, C.L. Lam, A.K. Lai, H.Y. Lo, and S.C. Chan Rare pulmonary complications after transarterial chemoembolisation for hepatocellular carcinoma: two case reports Hong Kong Med J 9 2003 457 460